Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 2/20 | 0.32 |
| ▸ | PPARA | Q07869 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6914565 | 0.82 | IAPP (0.40) | PPARGPPARA | |
| SCHEMBL9069836 | 0.81 | ALDH1A1 (0.39) | — | |
| SCHEMBL23140064 | 0.80 | ALDH1A1 (0.42) | PPARGPPARA | |
| SCHEMBL12313443 | 0.79 | TDP1 (0.39) | TDP1PPARGPPARA | |
| SCHEMBL12313007 | 0.78 | PPARG (0.47) | PPARGPPARA | |
| SCHEMBL12313645 | 0.76 | PPARG (0.44) | TDP1PPARGPPARA | |
| SCHEMBL23134822 | 0.76 | CHRNB2 (0.34) | — | |
| SCHEMBL24599195 | 0.76 | LMNA (0.36) | PPARGPPARA | |
| SCHEMBL24599174 | 0.76 | — | — | |
| SCHEMBL26577792 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029791-B2 | Therapeutic conjugates | TOTUS MEDICINES INC. (US) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029791-B2 | Therapeutic conjugates | CD47, CD44, EPCAM | TDP1 2678/4885PPARG 4484/4885PPARA 4453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.